White label ELPA - ClinicalTrials.eu

A Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer

Recruiting

3 1 1 1
Investigated Drugs:
- HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST SEZ6, CONJUGATED TO (2S)-2-(2-BROMOACETAMIDO)-N-[(2S)-1-({3-[(7S)-7-ETHYL-7-HYDROXY-8,11-DIOXO-7,8,11,13-TETRAHYDRO-2H,10H-[1,3]DIOXOLO[4,5-G]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-14-YL]BICYCLO[1.1.1]PENTAN-1-YL}AMINO)-1-OXOPROPAN-2-YL]-3-METHYLBUTANAMIDE
- Topotecan
+1
Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients

Recruiting

1 1 1 1
Investigated Drugs:
Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Recruiting

3 1 1
Investigated Diseases:
- Chronic kidney disease
Investigated Drugs:
- Azd5004
- Dapagliflozin
+8
Contraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles

Recruiting

3 1 1
Investigated Drugs:
- DROSPIRENONE
+1
A Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus

Recruiting

3 1 1 1
Investigated Drugs:
- Azd5004
- Semaglutide
Study comparing two forms of cagrilintide with placebo for weight loss in adults with overweight or obesity

Recruiting

3 1
Investigated Diseases:
- Obesity
- Overweight
Investigated Drugs:
- Cagrilintide
Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

Recruiting

3 1
Investigated Drugs:
- VOTOPLAM
+14
Phase 1b-2 Study of Safety and Preliminary Efficacy of LRK-4189 Alone or with Drug Combination in Patients with Solid Tumors

Recruiting

1 1 1 1
Investigated Drugs:
Study of PF-08653945 Bioavailability After Subcutaneous Injection in the Thigh, Upper Arm, or Abdomen in Adults with Obesity

Recruiting

1 1 1
Investigated Diseases:
- Overweight
Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

Recruiting

3 1
Investigated Drugs:
- ADX-324
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies